Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small molecule drugs and other compounds. In particular their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches.
Funding Rounds (2) - $43.5MUpdate
Board Members and Advisors (3)Update
Dansk Innovation was added to CrunchBase in 2009
Swiss PE firm
BioMedPartners is one of the leading European venture capital firms providing private equity and...
Wellington Partners is a venture capital firm that invests in technology and life sciences...
Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early...
Entrepreneurs Fund provides early stage and growth financing alongside active support to...